Viewing nowEmpaja Tablet 10 mg (Empagliflozin 2L-Proline)
Empagliflozin 2L-Proline 15.11mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202502902 · Approved 2025.11.10
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It can be used alone or in combination with other medications. It is particularly applicable to patients whose blood sugar is not sufficiently controlled, and additional precautions should be noted for patients with cardiovascular diseases. Overall, this medication helps in managing blood sugar and is effectively used in the treatment of type 2 diabetes.
The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered together with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This drug may be administered with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment This drug is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 when used to improve glycemic control. No dose adjustment is necessary for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this drug in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected in these patients. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in these patients. •Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, consider renal function and the risk of volume depletion (see Precautions for Use, 4. General Precautions).
This medication should not be used in patients with an allergy to the active ingredient or components, in patients with type 1 diabetes, or in those with diabetic ketoacidosis. Patients with impaired kidney function may experience reduced effectiveness of this medication, and regular monitoring of kidney function is required. It is not recommended for patients with certain kidney diseases. When used in conjunction with insulin or insulin secretagogues, the risk of hypoglycemia may increase, thus requiring dosage adjustments of these medications. Although this medication aids blood sugar control, side effects such as hypoglycemia, infections, increased urination, and decreased fluid volume may occur, warranting caution. There may be an increase in genital infections or urinary tract infections, and treatment should be sought immediately if symptoms appear. A serious metabolic disturbance known as ketoacidosis may occur; if symptoms such as vomiting, abdominal pain, or difficulty breathing arise, immediate consultation with medical personnel is required. Elderly patients or those at risk of fluid volume loss should be cautious regarding dehydration or hypotension, and may need to temporarily discontinue this medication if necessary. This medication has reported cases of liver damage, thus liver function tests should be performed if hepatic impairment is suspected. Serious infections such as urinary sepsis, pyelonephritis, and necrotizing fasciitis (a Fournier's gangrene) may occur rarely, and immediate treatment should be sought for related symptoms. Use during pregnancy is not recommended, and breastfeeding should be discontinued if this medication is taken. Safety and efficacy in children and adolescents have not been confirmed, thus it should not be used in this population. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment is necessary depending on clinical status. During the course of taking this medication, caution should be exercised while driving or operating machinery regarding the risk of hypoglycemia, especially when used in combination with insulin or sulfonylureas. It is important to maintain routine foot care and infection prevention, and to inform medical staff immediately of any unusual symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for an extended period.
Pale yellow oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 2L-Proline 15.11mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Empagliflozin 2L-Proline 15.107mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Empagliflozin 2L-Proline 37.766mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Empagliflozin 2L-Proline 37.77mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Empagliflozin 2L-Proline 15.12mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Empagliflozin 2L-Proline 37.8mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.